Use of budget savings from patent expiration of cancer drugs to improve affordability and accessibility

BACKGROUND: The introduction of generics after the loss of patent exclusivity plays a major role in budget savings by significantly decreasing drug prices. The aims of this study were to estimate the budget savings from off-patent cancer drugs in 2020–2024 and to inform decision makers on how these...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Seung Mi, Kim, Heui Jae, Suh, David, Joung, Kyung-In, Kim, Eun Suk, Back, Hee Jung, Kwon, Jun Young, Park, Man-Jae, Suh, Dong Churl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866447/
https://www.ncbi.nlm.nih.gov/pubmed/33549099
http://dx.doi.org/10.1186/s12913-021-06130-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866447/
https://www.ncbi.nlm.nih.gov/pubmed/33549099
http://dx.doi.org/10.1186/s12913-021-06130-y

Ejemplares similares